Literature DB >> 24696151

Evaluation of different approaches for confounding in nonrandomised observational data: a case-study of antipsychotics treatment.

E Sarlon1, A Millier, S Aballéa, M Toumi.   

Abstract

Although randomised controlled trials are regarded as the gold standard for treatments efficacy, evidence from observational studies remains relevant. To address the problem of possible confounding in these studies, investigators must employ analysis methods that adjust for confounders and lead to an unbiased estimation of the treatment effect. In this paper, the authors describe two relevant statistical methods. The first method represents the classical approach consisting of a multiple regression model including the effects of treatment and covariates. This approach considers the relation between prognostic factors and the outcome variable as a relevant criterion for adjustment. The second method is based on the propensity score, and focuses on the relation between prognostic factors and treatment assignment. These approaches were applied to a cohort of 183 French schizophrenic patients who were followed for a 2-year period (from 1998 to 2000). The probability of relapse according to antipsychotic treatment exposure was modelled using Cox regression models with the two statistical methods. Goodness-of-fit criteria were used to compare the modelling approaches. This study demonstrates that the propensity score, a predicted probability, has an important balancing property that underscores its value in strengthening the results of nonrandomised observational studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24696151     DOI: 10.1007/s10597-014-9723-x

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  64 in total

Review 1.  Methods to assess intended effects of drug treatment in observational studies are reviewed.

Authors:  Olaf H Klungel; Edwin P Martens; Bruce M Psaty; Diederik E Grobbee; Sean D Sullivan; Bruno H Ch Stricker; Hubert G M Leufkens; A de Boer
Journal:  J Clin Epidemiol       Date:  2004-12       Impact factor: 6.437

2.  [Propensity score: interest and limits].

Authors:  Fabrice Kwiatkowski; Karem Slim; Pierre Verrelle; Emmanuel Chamorey; Andrew Kramar
Journal:  Bull Cancer       Date:  2007-07       Impact factor: 1.276

3.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

Review 4.  Gender and duration of untreated psychosis: a systematic review and meta-analysis.

Authors:  Maria Teresa Cascio; Matteo Cella; Antonio Preti; Anna Meneghelli; Angelo Cocchi
Journal:  Early Interv Psychiatry       Date:  2012-03-02       Impact factor: 2.732

5.  The SF 36 health survey questionnaire. A valid measure of health status...

Authors:  D Ruta; A Garratt; M Abdalla; K Buckingham; I Russell
Journal:  BMJ       Date:  1993-08-14

6.  A depression rating scale for schizophrenics.

Authors:  D Addington; J Addington; B Schissel
Journal:  Schizophr Res       Date:  1990 Jul-Aug       Impact factor: 4.939

7.  Specificity of the Calgary Depression Scale for schizophrenics.

Authors:  D Addington; J Addington; E Maticka-Tyndale
Journal:  Schizophr Res       Date:  1994-02       Impact factor: 4.939

8.  Overadjustment bias and unnecessary adjustment in epidemiologic studies.

Authors:  Enrique F Schisterman; Stephen R Cole; Robert W Platt
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

9.  The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.

Authors:  Troy A Moore; Robert W Buchanan; Peter F Buckley; John A Chiles; Robert R Conley; M Lynn Crismon; Susan M Essock; Molly Finnerty; Stephen R Marder; Del D Miller; Joseph P McEvoy; Delbert G Robinson; Nina R Schooler; Steven P Shon; T Scott Stroup; Alexander L Miller
Journal:  J Clin Psychiatry       Date:  2007-11       Impact factor: 4.384

Review 10.  Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses.

Authors:  James B Kirkbride; Antonia Errazuriz; Tim J Croudace; Craig Morgan; Daniel Jackson; Jane Boydell; Robin M Murray; Peter B Jones
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

View more
  1 in total

1.  Mortality Rates in Users of Typical and Atypical Antipsychotics: A Database Study in Poland.

Authors:  Pawel Zagozdzon; Bartosz Goyke; Magdalena Wrotkowska
Journal:  Drugs Real World Outcomes       Date:  2016-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.